FIRST LINE CHEMOTHERAPY OF FOLFOX REGIMEN IN AN INTERMITTENT REGIMEN IN A PATIENT WITH HER2-NEGATIVE GASTRIC CANCER
E.V. Dementeva1, O.I. Kaganov2, 3, I.B. Ermakov1 1Meditsinskaya Kompaniya IDK JSC, Samara 2Samara Regional Clinical Oncological Dispensary, Samara 3Samara State Medical University, Samara Dementeva E.V. – oncologist of the Department of Antitumor Therapy 29 Entuziastov St., 443067, Samara, Russian Federation, tel.: +7-917-152-21-27, e-mail: dementeva.ek98@mail.ru, ORCID ID: 0000-0001-9361-6354 Abstract. About one million new cases of gastric … Читать далее